Harrod, A <br/><br/>
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.  [electronic resource] 

 -  Oncogene  04 2017 
 - 2286-2296 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2016.382  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>CRISPR-Cas Systems<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Estrogen Antagonists--pharmacology<br/>Estrogen Receptor alpha--genetics<br/>Estrogens--pharmacology<br/>Female<br/>Gene Knock-In Techniques<br/>Histones--metabolism<br/>Humans<br/>MCF-7 Cells<br/>Mutation<br/>Phosphorylation<br/>Serine--metabolism<br/>Tamoxifen--analogs & derivatives<br/>Cyclin-Dependent Kinase-Activating Kinase